Skip to main content
Caplight Logo









AbFinder Therapeutics Co., Ltd.

AbFinder Therapeutics Co., Ltd.

Private
AnyangHealthcare & Life Scienceshttps://abfindertrx.com/

Last Round

Seed

Sep 30, 2025

Total Funding Raised

$740,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AbFinder Therapeutics Co., Ltd. is a biopharmaceutical company that develops innovative antibody discovery and engineering platform technologies, including its proprietary PepFc® platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

antibody discoveryantibody engineeringantibody-drug conjugatesADCpeptide technologybiopharmaceutical R&Dbispecific antibodiesdrug discovery platformprotein therapeuticsantibody miniaturizationbioinformaticsdrug pipelinebiotech licensingbiotech startupdrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AbFinder Therapeutics Co., Ltd. Comparables

Compare AbFinder Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.

AbFinder Therapeutics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Harbour BioMed
68%
Y-Biologics
66%
AbClon Inc.
66%

AbFinder Therapeutics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 30, 2025

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 30, 2025

    $740K raised in Seed round.

AbFinder Therapeutics Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

AbFinder Therapeutics Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AbFinder Therapeutics Co., Ltd.'s valuation, stock price, and market status.

Is AbFinder Therapeutics Co., Ltd. a public or private company?

AbFinder Therapeutics Co., Ltd. is a private company.

What is the current stock price of AbFinder Therapeutics Co., Ltd.?

AbFinder Therapeutics Co., Ltd. is a private company with no public stock price. Caplight tracks AbFinder Therapeutics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is AbFinder Therapeutics Co., Ltd. worth (valuation)?

Valuation information for AbFinder Therapeutics Co., Ltd. is not publicly available.

Can I buy AbFinder Therapeutics Co., Ltd. stock?

AbFinder Therapeutics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AbFinder Therapeutics Co., Ltd.'s last funding round?

AbFinder Therapeutics Co., Ltd.'s most recent funding round was Seed on September 30, 2025.

Who are the main investors in AbFinder Therapeutics Co., Ltd.?

Investor information for AbFinder Therapeutics Co., Ltd. is not publicly disclosed.

Will AbFinder Therapeutics Co., Ltd. IPO soon?

No public IPO plans have been announced for AbFinder Therapeutics Co., Ltd..

How can I track AbFinder Therapeutics Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AbFinder Therapeutics Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAnyang
Year Founded2024
Last FundingSep 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?